Tiny Health Baby Gut Types


  • Tiny Health Baby Gut Type gives you a unique perspective and understanding of your baby's gut development within their first year.
  • If your baby doesn’t have an optimal Baby Gut Type, the good news is that baby gut types are modifiable and there’s plenty of room for improvement.
  • Two key events help determine which Baby Gut Type your baby has: vaginal or C-section birth and how your baby is fed.

At Tiny Health, we developed seven Baby Gut Types to simplify the way we talk about the baby gut microbiome. Each gut type gives you a unique perspective and understanding of your baby's gut development within their first year.

Take Note: Tiny Health Baby Gut Subtypes A and B

Each one of these seven Baby Gut Types can further be subdivided into A or B subtypes. This will depend on the level of protective bifidobacteria present in your baby’s gut.

  • Subtype A: medium or high bifidobacteria
  • Subtype B: low bifidobacteria

For example, if your baby is Type 2A, it means that the dominant bacteria in their gut are Bacteroidaceae but bifidobacteria are present at a healthy level.

On the other hand, if your baby is Type 4B, they mostly have Enterococcus and low bifidobacteria. Which is when we would suggest a little extra support.

What are the different Tiny Health Baby Gut Types?

Type 1: Bifidobacterium-dominated

Bifidobacteria are friendly bacteria associated with good health. So ideally, they’re present in the baby’s gut from birth onward, although we would expect higher levels in babies and children under the age of three.

In many ways, bifidobacteria are your baby’s best friends. For example, they:

  • Produce lactate and short-chain fatty acids (SCFAs) like acetate when they digest human milk oligosaccharides (HMOs), which makes it hard for unfriendly gut bacteria to survive [1]
  • Play an important role in educating your baby’s immune system [2]–[5]
  • Promote the presence of a healthy microbiome by supporting the growth of other bifidobacteria [2], [6]
  • Provide nutrition, by synthesizing essential micronutrients, such as vitamins B12, B6, folate, and vitamin K [7]

Baby Gut Type 1 is linked to a vaginal birth with few medical interventions and breastfeeding. As it turns out, breastfeeding has a significant impact on the development of bifidobacteria. Within a couple weeks of breastfeeding, a baby born via C-section can have comparable levels of bifidobacteria as a baby born vaginally [8].

As long as your baby is breastfed, bifidobacteria will generally remain high in your baby’s gut during their first 6 months of life [9]. This is important because low levels of bifidobacteria in babies are linked to chronic diseases, including autoimmunity, asthma and obesity [10]–[12].

Type 2: Bacteroidaceae-dominated

Bacteroidaceae are generally friendly gut bacteria and they’re found in almost all people.

Some species of Bacteroidaceae can degrade some of the sugars in breastmilk (HMOs) which is good for your baby [13]. That said, they may not be as efficient as bifidobacteria in breaking down all types of HMOs [14]. A Bacteroidaceae-dominant baby gut is linked to vaginal births, especially home births [14], and may help prepare your baby’s gut for the introduction of solid food [15], [16].

Together with bifidobacteria, Bacteroidaceae play a major role in the early gut microbiome.

It is important to note that Bacteroides are absent in almost all babies born by C-section delivery [17] and are particularly affected by antibiotics given to the mom either before or during labor [18], [19]. If it’s an option for you, we advocate for an antibiotic-free vaginal birth so that your baby’s gut can shelter the best bacteria possible.

Type 3: Enterobacteriaceae-dominated

Enterobacteriaceae are bacteria found almost everywhere in nature, including the baby’s gut. But this doesn’t mean we want to see this family of bacteria dominating the baby’s gut.

Some species are friendly and even desired in the newborn gut [12]. However, at high enough levels, some Enterobacteriaceae can cause serious problems due to their pro-inflammatory properties [20]. For example, Klebsiella species were associated with the development of a higher incidence of respiratory infection later in life [21].

Many Enterobacteriaceae species often carry genes related to antibiotic resistance that allow them to survive exposure to antibiotics designed to kill bacteria [22], [23], and are particularly dangerous in premature babies [24].

Because Enterobacteriaceae are common members of the hospital environment, this gut type is frequently seen in C-section born babies, vaginal hospital births, and babies born prematurely, who often have to spend extensive time in hospital.

Type 4: Enterococcus-dominated

Baby Gut Type 4 is dominated by enterococci. Some species of Enterococcus can swing both ways, making them both friendly and unfriendly [25]. Either way, if this bacteria dominates your baby’s gut, it’s likely not ideal.

Baby Gut Type 4 is linked to both vaginal and C-section births [21].The presence of Enterococcus faecalis in babies has been associated with respiratory infections [21] and E. faecalis is more likely than other bacteria to carry genes related to antibiotic resistance [26].

When these unfriendly species dominate your baby’s microbiome, you may want to consider decreasing E. faecalis levels and increasing the levels of beneficial bifidobacteria.

This is not a very common gut type.

Type 5: Streptococcus-dominated

Baby Gut Type 5 is dominated by streptococci bacteria. Streptococci are mostly found in the mouth, stomach, and small intestine of healthy people.

They can be a small part of a healthy early life microbiome community but are not ideal to have as a dominant baby gut type. Some Streptococcus may increase the risk for eczema [27] and type I diabetes [28]. However, more data is needed to determine if these relationships are causal.

This is not a very common gut type.

Type 6: Staphylococcus-dominated

Staphylococcus is mostly found on the skin and is not adapted to live in the baby or adult gut.

But these bacteria are sometimes found to colonize the gut of babies born through C-section delivery [19], [29]. High levels of staphylococci define Baby Gut Type 6. It’s important to note that we expect Staphylococcus to decrease quickly throughout the first months of life as it is outcompeted by other species that are better adapted to living in the gut [28], [30].

Colonization of newborn babies with Staphylococcus aureus may increase the risk of infection in early life [31] and the presence of S. aureus in the nose of children has been associated with asthma [32]–[34]. While we’ll keep you updated as more research becomes available, it’s clear that you do not want Staphylococcus to be dominant in your baby's gut.

This is not a very common gut type.

Type 7: Other

Sometimes a baby's gut microbiome does not fit into any of the six Baby Gut Types that we defined. If your baby is type 7 that means that a high percentage of the bacteria present in their gut are species that we don’t normally see dominating the baby gut.

Before 6 months, this is quite rare and is usually linked to a C-section birth, vaginal birth with medical interventions, or formula-feeding [18], [35], [36].

If your baby is 6 months or older and Type 7, don’t be alarmed. This Baby Gut Type is a sign that the microbiome has started to diversify. It may be normal if your baby has started solids or weaned from breastmilk, which can take place between 6-9 months.

Take note: You can change your baby’s gut type

A baby’s gut microbiome is highly malleable and continues to develop and change throughout the first 3-5 years of your baby’s life.

The optimal Tiny Health Baby Gut Type is the one that gives your baby the best start by providing them with health-promoting microbes, such as bifidobacteria. If it’s available to you, continue breastfeeding your baby to maintain or increase bifidobacteria levels.

If you need to increase bifidobacteria levels in your baby’s gut but breastfeeding isn’t an option, you can consider supplementing with the right kind of probiotics for your baby or using a formula with HMO prebiotics.


[1] S. Fukuda et al., “Bifidobacteria can protect from enteropathogenic infection through production of acetate,” Nature, vol. 469, no. 7331, pp. 543–547, 2011, doi: 10.1038/nature09646.
[2] I. O’Neill, Z. Schofield, and L. J. Hall, “Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases,” Emerg Top Life Sci, vol. 1, no. 4, pp. 333–349, 2017, doi: 10.1042/etls20170058.
[3] B. M. Henrick et al., “Bifidobacteria-mediated immune system imprinting early in life,” Cell, 2021, doi: 10.1016/j.cell.2021.05.030.
[4] B. M. Henrick et al., “Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants,” Pediatr Res, vol. 86, no. 6, pp. 749–757, 2019, doi: 10.1038/s41390-019-0533-2.
[5] J. E. Spreckels and A. Zhernakova, “Milk and bugs educate infant immune systems,” Immunity, vol. 54, no. 8, pp. 1633–1635, 2021, doi: 10.1016/j.immuni.2021.07.013.
[6] S. A. Frese et al., “Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants,” Msphere, vol. 2, no. 6, pp. e00501-17, 2017, doi: 10.1128/msphere.00501-17.
[7] C. M. Dieterich, J. P. Felice, E. O’Sullivan, and K. M. Rasmussen, “Breastfeeding and Health Outcomes for the Mother-Infant Dyad,” Pediatr Clin N Am, vol. 60, no. 1, pp. 31–48, 2013, doi: 10.1016/j.pcl.2012.09.010.
[8] M. O. Coker et al., “Infant Feeding Alters the Longitudinal Impact of Birth Mode on the Development of the Gut Microbiota in the First Year of Life,” Front Microbiol, vol. 12, p. 642197, 2021, doi: 10.3389/fmicb.2021.642197.
[9] C. J. Stewart et al., “Temporal development of the gut microbiome in early childhood from the TEDDY study,” Nature, vol. 562, no. 7728, pp. 583–588, 2018, doi: 10.1038/s41586-018-0617-x.
[10] K. E. Fujimura et al., “Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation,” Nat Med, vol. 22, no. 10, pp. 1187–1191, 2016, doi: 10.1038/nm.4176.
[11] J. Stokholm et al., “Maturation of the gut microbiome and risk of asthma in childhood,” Nat Commun, vol. 9, no. 1, p. 141, 2018, doi: 10.1038/s41467-017-02573-2.
[12] T. Vatanen et al., “Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans,” Cell, vol. 165, no. 4, pp. 842–853, 2016, doi: 10.1016/j.cell.2016.04.007.
[13] A. Marcobal et al., “Bacteroides in the Infant Gut Consume Milk Oligosaccharides via Mucus-Utilization Pathways,” Cell Host Microbe, vol. 10, no. 5, pp. 507–514, 2011, doi: 10.1016/j.chom.2011.10.007.
[14] J. L. Combellick et al., “Differences in the fecal microbiota of neonates born at home or in the hospital,” Sci Rep-uk, vol. 8, no. 1, p. 15660, 2018, doi: 10.1038/s41598-018-33995-7.
[15] J. E. Koenig et al., “Succession of microbial consortia in the developing infant gut microbiome,” Proc National Acad Sci, vol. 108, no. Supplement 1, pp. 4578–4585, 2011, doi: 10.1073/pnas.1000081107.
[16] A. Marcobal and J. L. Sonnenburg, “Human milk oligosaccharide consumption by intestinal microbiota,” Clin Microbiol Infec, vol. 18, no. s4, pp. 12–15, 2012, doi: 10.1111/j.1469-0691.2012.03863.x.
[17] C. M. Mitchell et al., “Delivery Mode Affects Stability of Early Infant Gut Microbiota,” Cell Reports Medicine, vol. 1, no. 9, p. 100156, 2020, doi: 10.1016/j.xcrm.2020.100156.
[18] M. B. Azad et al., “Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study,” Bjog Int J Obstetrics Gynaecol, vol. 123, no. 6, pp. 983–993, 2016, doi: 10.1111/1471-0528.13601.
[19] Y. Shao et al., “Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth,” Nature, vol. 574, no. 7776, pp. 117–121, 2019, doi: 10.1038/s41586-019-1560-1.
[20] M. Y. Zeng, N. Inohara, and G. Nuñez, “Mechanisms of inflammation-driven bacterial dysbiosis in the gut,” Mucosal Immunol, vol. 10, no. 1, pp. 18–26, 2017, doi: 10.1038/mi.2016.75.
[21] M. Reyman et al., “Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life,” Nat Commun, vol. 10, no. 1, p. 4997, 2019, doi: 10.1038/s41467-019-13014-7.
[22] R. M. Lebeaux et al., “The infant gut resistome is associated with E. coli and early-life exposures,” Bmc Microbiol, vol. 21, no. 1, p. 201, 2021, doi: 10.1186/s12866-021-02129-x.
[23] A. J. Gasparrini et al., “Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome,” Nat Microbiol, vol. 4, no. 12, pp. 2285–2297, 2019, doi: 10.1038/s41564-019-0550-2.
[24] C. J. Hill et al., “Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort,” Microbiome, vol. 5, no. 1, p. 4, 2017, doi: 10.1186/s40168-016-0213-y.
[25] B. Krawczyk, P. Wityk, M. Gałęcka, and M. Michalik, “The Many Faces of Enterococcus spp.—Commensal, Probiotic and Opportunistic Pathogen,” Microorg, vol. 9, no. 9, p. 1900, 2021, doi: 10.3390/microorganisms9091900.
[26] W. R. Miller, J. M. Munita, and C. A. Arias, “Mechanisms of antibiotic resistance in enterococci,” Expert Rev Anti-infe, vol. 12, no. 10, pp. 1221–1236, 2014, doi: 10.1586/14787210.2014.956092.
[27] Y. M. Park et al., “Imbalance of Gut Streptococcus, Clostridium, and Akkermansia Determines the Natural Course of Atopic Dermatitis in Infant,” Allergy Asthma Immunol Res, vol. 12, no. 2, pp. 322–337, 2019, doi: 10.4168/aair.2020.12.2.322.
[28] A. D. Kostic et al., “The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes,” Cell Host Microbe, vol. 17, no. 2, pp. 260–273, 2015, doi: 10.1016/j.chom.2015.01.001.
[29] J. Stokholm et al., “Cesarean section changes neonatal gut colonization,” J Allergy Clin Immun, vol. 138, no. 3, pp. 881-889.e2, 2016, doi: 10.1016/j.jaci.2016.01.028.
[30] S. Subramanian et al., “Persistent gut microbiota immaturity in malnourished Bangladeshi children,” Nature, vol. 510, no. 7505, pp. 417–421, 2014, doi: 10.1038/nature13421.
[31] A. van Belkum et al., “Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus,” Infect Genetics Evol, vol. 9, no. 1, pp. 32–47, 2009, doi: 10.1016/j.meegid.2008.09.012.
[32] M. F. Davis, R. D. Peng, M. C. McCormack, and E. C. Matsui, “Staphylococcus aureus colonization is associated with wheeze and asthma among US children and young adults,” J Allergy Clin Immun, vol. 135, no. 3, pp. 811-813.e5, 2015, doi: 10.1016/j.jaci.2014.10.052.
[33] C. Bachert et al., “Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge,” Eur Respir J, vol. 55, no. 4, p. 1901592, 2020, doi: 10.1183/13993003.01592-2019.
[34] Y.-C. Kim et al., “Staphylococcus aureus Nasal Colonization and Asthma in Adults: Systematic Review and Meta-Analysis,” J Allergy Clin Immunol Pract, vol. 7, no. 2, pp. 606-615.e9, 2019, doi: 10.1016/j.jaip.2018.08.020.
[35] H. M. Hesla et al., “Impact of lifestyle on the gut microbiota of healthy infants and their mothers – the ALADDIN birth cohort,” Fems Microbiol Ecol, vol. 90, no. 3, pp. 791–801, 2014, doi: 10.1111/1574-6941.12434.
[36] J. Ma et al., “Comparison of gut microbiota in exclusively breast-fed and formula-fed babies: a study of 91 term infants,” Sci Rep-uk, vol. 10, no. 1, p. 15792, 2020, doi: 10.1038/s41598-020-72635-x.
[37] M. G. Dominguez-Bello et al., “Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns,” Proc National Acad Sci, vol. 107, no. 26, pp. 11971–11975, 2010, doi: 10.1073/pnas.1002601107.
[38] F. Bäckhed et al., “Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life,” Cell Host Microbe, vol. 17, no. 5, pp. 690–703, 2015, doi: 10.1016/j.chom.2015.04.004.
[39] P. S. Pannaraj et al., “Association Between Breast Milk Bacterial Communities and Establishment and Development of the Infant Gut Microbiome,” Jama Pediatr, vol. 171, no. 7, p. 647, 2017, doi: 10.1001/jamapediatrics.2017.0378.
[40] T. Ding and P. D. Schloss, “Dynamics and associations of microbial community types across the human body,” Nature, vol. 509, no. 7500, pp. 357–360, 2014, doi: 10.1038/nature13178.